hemoglobin. Researchers recently developed a new biomarker-based bleeding risk score for patients with atrial fibrillation (AF) to help decision making about oral anticoagulation. ... The ABC-bleeding score should therefore “be useful as decision
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a ... patients regarding anticoagulant treatment
New afib guideline recommends a more comprehensive stroke risk calculator and includes novel anticoagulants as treatment options
A new guideline for managing nonvalvular atrial fibrillation recommends using the CHA2DS2-VASc stroke risk calculator, and adds 3 new anticoagulants as treatment options. ... Level of Evidence: B). 4. For patients with nonvalvular AF with prior stroke,
Researchers used the Veterans Affairs Study to Improve Anticoagulation database to identify 1,763 patients with liver disease who were receiving oral anticoagulation with warfarin from Oct. ... The authors noted that most of the study patients were men
New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy
Patients with severe cardiac, renal or liver insufficiency and those with high bleeding risk (including those requiring long-term oral anticoagulation) were excluded. ... He called for additional research to examine the use of newer anticoagulants in
In patients with atrial fibrillation, the advantages of all 4 new oral anticoagulants over warfarin seem to outweigh the risks, a new meta-analysis found. ... This meta-analysis “support(s) the premise that compared with warfarin, new oral
mitral valve involvement (HR, 1.29) or if they received anticoagulant therapy (HR 1.31). ... Based on these results, it seems advisable to avoid anticoagulant therapy in patients with these other risk factors, the study authors concluded.
Higher CHADS. 2. scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study. ... However, they concluded that increasing CHADS. 2.
A significant bleeding complication was defined as a need for pocket exploration or blood transfusion, hematoma requiring pressure dressing or change in anticoagulation therapy, or prolonged hospitalization. ... 4.3%; P<.001) and those who got no
Illustration by David Rosenman. When I first heard of the novel virus, I thought of novel anticoagulants.